Vmbook Online ordering

Icons

**About List-Check (LIST)**

List-Check is a publicly traded company headquartered in Dallas, Texas. It provides software and services for the healthcare industry, specializing in patient scheduling and revenue cycle management. The company's stock is traded on the Nasdaq Stock Market under the symbol LIST.

**Key Financials**

* **Revenue:** $140.2 million (2022)

* **Net Income:** $13.4 million (2022)

* **Earnings Per Share (EPS):** $0.67 (2022)

* **Market Capitalization:** $575 million (as of March 8, 2023)

**Growth and Performance**

* **Revenue Growth:** 11.4% year-over-year (2022)

* **EPS Growth:** 14.3% year-over-year (2022)

* **Gross Margin:** 64.5%

* **Operating Margin:** 11.4%

**List-Check's Business**

The company's software platform, PatientNow, is used by healthcare providers to manage patient scheduling, billing, and other administrative tasks. List-Check also offers a suite of services, including revenue cycle management, patient engagement, and data analytics.

**Key Competitors**

* Athenahealth

* Cerner

* Epic Systems

* GE Healthcare

**Recent Developments**

* In 2022, List-Check acquired PatientPay, a provider of patient payment solutions.

* The company has been investing in its software platform and expanding its product offerings.

* List-Check has been recognized for its strong financial performance and customer satisfaction.

**Investment Considerations**

* List-Check is a growing company in a high-growth industry.

* The company's software platform is well-regarded in the healthcare market.

* List-Check has a strong financial position and is profitable.

* However, the company faces competition from larger players in the industry.

* Investors should carefully consider the company's growth potential and competitive landscape before making an investment decision.